Ranjodh Singh Gill

Ranjodh Singh Gill's work experience includes serving as an Associate Director of Clinical (GCP) Quality Assurance at MorphoSys since 2023. Prior to that, they worked at Grünenthal Group as a Clinical Quality Manager in R&D Quality from 2018 to 2022 and as a Global GMP Auditor in External Supply QA from 2018 to 2021. Before joining Grünenthal Group, they worked at Parexel as a Compliance Manager in QA-GCP from 2016 to 2018 and as a Sr. GxP Auditor in Quality Assurance from 2010 to 2016. Their earliest work experience was at Ranbaxy, where they served as a Sr. Quality Assurance Officer in GMP from 2005 to 2010.

Ranjodh Singh Gill began their education in 1996 at Kendriya Vidyalaya, where they completed their High School education with a focus on Physics, Chemistry, and Biology in 1998. Following this, from 1998 to 2001, they attended Guru Nanak Dev University, where they earned a Bachelor of Science (BS) degree in Natural Sciences.

In 2001, Ranjodh enrolled at Punjab Infotech, CAL-C, where they pursued a Post Graduate Diploma in Computer Applications with a specialization in Computer Science. This program lasted for one year until 2002.

After completing the diploma, they continued their studies at Maharshi Dayanand University from 2002 to 2003, completing a Master of Science (MS) degree in Computer Science.

Ranjodh then furthered their education at Guru Nanak Dev University from 2003 to 2005. During this time, they earned a Master of Science (M.Sc.) degree in Applied Chemistry (Pharmaceuticals).

In 2017, Ranjodh attended Duke-NUS Medical School and participated in a Seminar Series at the Centre of Regulatory Excellence. It is not specified when this seminar series ended or if they earned a degree through it.